期刊文献+

急性冠状动脉综合征患者血小板CD40L表达及其临床意义 被引量:2

Variation of CD40L level on platelet and its clinic significance in acute coronary syndrome
原文传递
导出
摘要 目的:探讨急性冠状动脉综合征(ACS)患者血小板CD40L表达的临床意义及其与血浆高敏C反应蛋白(hs-CRP)的关系。方法:收集稳定型心绞痛患者17例、ACS20例、正常对照15例,所有病例均行冠状动脉造影,采用流式细胞技术检测血小板CD40L的表达,采用免疫增强的透视比浊法检测血浆hs-CRP水平。结果:ACS组血小板CD40L的平均荧光强度(17.26±7.62)显著高于稳定型心绞痛组(10.81±2.94,P<0.01)和正常对照组(8.78±4.13,P<0.01)。ACS组血浆hs-CPR水平(8.11±6.67)mg/L显著高于稳定型心绞痛组[(2.79±1.24)mg/L,P<0.01]和正常对照组[(1.98±1.29)mg/L,P<0.01]。冠心病患者血小板CD40L及血浆hs-CRP与冠状动脉病变支数无相关性。冠心病患者血小板CD40L与血浆TC呈正相关(r=0.289,P<0.05)。与血浆hs-CPR、HDL、LDL、TG无相关性。结论:ACS患者血小板CD40L、血浆hs-CRP水平明显增高,血小板CD40L可能是反映斑块稳定性的指标之一。 Objective:To elucidate the clinical significance of the CD40L expression on platelet in acute coronary syndrome(ACS) and the relation between platelet CD40L level and circulating level of high-sensitivity C-reactiveprotein ( hs- CRP ). Method : This is a cross-sectional study. All patients who were taken Coronary angiography were divided into three groups: 15 patients in the control group with negative results in coronary, 17 patients in stable angina pectoris (SAP) group, 20 patients in ACS group. Flow-cytometry technology was used to measure the CD40L level on platelet and Particle enhanced immunoturbidimetric assay was used to measure the plasma hs- CRP level. Result:CD40L level on platelet was significantly higher in patients with ACS (17.26 ± 7.62MFI) than that in control group(8. 78±4.13MFI, P〈0.01) and in patients with SAP (10. 81±2.94MFI, P〈0. 01). Plasma hs-CRP level was significantly higher in patients with ACS (8.11 ± 6.67 mg/L) than that in control group (1. 98±1.29 mg/L,P〈0. 01) and in patients with SAP (2. 79±1.24 mg/L, P〈0.01). CD40L level on platelet and plasma hs-CRP level had no correlation with the number of lesion vessels in patients with coronary heart dis- ease. CD40L level on platelet had significantly positive correlation with plasma total cholesterol (r = 0. 289, P = 0. 037). CD40L had no correlation with plasma hs-CRP, triglyceride, low density lipoprotein cholesterol and high density lipoprotein cholesterol. Conchlsion:CD40L level on platelet and hs-CRP level in plasma were higher in patients with ACS than those in SAP. CD40L level on platelet may be a marker indicating unstable plaque.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2007年第11期815-818,共4页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 CD40配体 抗原 人血小板 C反应蛋白 Acute coronary syndrome CD40 Ligand Antigens, human platelet C-reactive protein
  • 相关文献

参考文献12

  • 1HENN V,SLUPSKY J R,GRAFE M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells[J].Nature,1998,391:591-594.
  • 2MACH F,SCHONBECK U,SUKHOVA G K,et al.Reduction of atherosclerosis in mice by inhibition of CD40 signalling[J].Nature,1998,394:200-203.
  • 3SCHONBECK U,SUKHOVA G K,SHIMIZU K,et al.Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J].Proc Natl Acad Sci U S A,2000,97:7458-7463.
  • 4SCHONBECK U,VARO N,LIBBY P,et al.Soluble CD40L and cardiovascular risk in women[J].Circulation,2001,104:2266-2268.
  • 5HEESCHEN C,DIMMELER S,HAMM C W,et al.Soluble CD40 ligand in acute coronary syndromes[J].N Engl J Med,2003,348:1163-1165.
  • 6PARIS D,TOWNT,HUMPHREY J,et al.Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway[J].Biochem Biophys Res Commun,2000,274:553-558.
  • 7GARLICHS C D,JOHN S,SCHMEISSER A,et al.Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia[J].Circulation,2001,104:2395-2400.
  • 8ANDRIE R,MAYLAHN M,BRAUN P,et al.Creactive protein in coronary plaques--prevalence with acute coronary syndrome[J].Z Kardiol,2002,91:913-920.
  • 9ABDELMOUTTALEB I,DANCHIN N,ILARDO C,et al.C-reactive protein and coronary artery disease:Additional evidence of the implication of an inflammatory process in acute coronary synodromes[J].Am Heart J,1999,137:346-351.
  • 10葛智平,陈晓春.C反应蛋白与不同类型冠心病相关性的临床研究[J].临床心血管病杂志,2005,21(2):78-80. 被引量:37

二级参考文献8

  • 1Liuzzo G, Biasucci L M, Gallimore J R, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med, 1994, 331: 417-424.
  • 2Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000, 342: 836-843.
  • 3Kuller L H, Tracy R P, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol, 1996,144: 537-547.
  • 4Iftihar J K, Willian D E, Robert S S. Vulnerable plaque: Pathobiology and clinical implication. Ann Inter Med, 1998, 129:1050-1060.
  • 5Prediman K, Shah M D. Plaque disruption and thrombosis: Potential role of inflammation and infection. Cardiol Rev, 2000, 8: 32-39.
  • 6Haught W H, Mansour M, Rothlein R, et al. Alteration on circulating intercellular adhesion molexule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J, 1996, 132: 1-6.
  • 7Lagrand W K, Niessen H W. C-reactive protein colocaliaes with complement in human hearts during acute myocardial infarction. Circulation, 1997, 95: 97-103.
  • 8裴志勇,杨庭树,杜洛山,盖鲁粤,王禹.不稳定型心绞痛炎性因子与冠状动脉病变的对比研究[J].临床心血管病杂志,2002,18(7):308-310. 被引量:27

共引文献36

同被引文献17

  • 1Naruko T, Ueda M, Haze K, et al,Neutrophil infiltration of culprit lesions in acute coronary syndromes.Circulation [J]. 2002, 106 : 2894-2900.
  • 2Garliehs C D, Eskafi S, Cicha 1, et al. Delay of neutrophil apoptosis in acute coronary syndromes [J]. J Leukoc Biol, 2004,75 : 828-835.
  • 3Vanichakarn P, Blair P, Wu C, et al. Neutrophil CD40 enhances platelet-mediated inflammation. Thromb tles [J]. 2008,122 (3) : 346-358.
  • 4Jin Y,Nonoyama S,Morio T. Characterization of soluble CD40 ligand released from human activated platelets[J].Journal of Medical and Dental Sciences,2001,(01):23-27.
  • 5Achar S A,Kundu S,Norcross W A. Diagnosis of acute coronary syndrome[J].American Family Physician,2005,(01):119-126.
  • 6Murphy S A,Cannon C P,Wiviott S D. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)[J].American Journal of Cardiology,2007,(07):1047-1051.
  • 7Rosenson R S,Tangney C C. Antiatherothrombotic properties of statins:implications for cardiovascular event reduction[J].Journal of the American Medical Association,1998,(20):1643-1650.
  • 8Abu el-Makrem M A,Mahmoud Y Z,Sayed D. The role of platelets CD40 ligand (CD154) in acute coronary syndromes[J].Thrombosis Research,2009,(06):683-688.doi:10.1016/j.thromres.2009.06.028.
  • 9Andre P,Prasad K S,Denis C V. CD40L stabilizes arterial thrombi by a beta-3 integrin dependent mechanism[J].Nature Medicine,2002,(03):247-252.
  • 10Pastuszczak M,Kotlarz A,Mostowik M. Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction[J].Thrombosis Research,2010,(05):382-386.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部